EV Biologics, Inc.

EV Biologics, Inc.

YECO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.09K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
EV Biologics, Inc.EV Biologics, Inc.0-4%--0.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4,090.00
Enterprise Value$1.50 Million
Earnings per Share$-0.03
Beta0.45
Outstanding Shares10,225,376

Return

Return on Equity3.99%ROE
Return on Assets-15.97%
Return on Invested Capital3.99%

Valuation & Multiples

P/E Ratio-0.04P/E Ratio
PEG0.03PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue15.45
Enterprise Value to EBIT-18.21
Enterprise Value to Net Income-19
Total Debt to Enterprise1
Debt to Equity-0.72Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About EV Biologics, Inc.

284 employees
CEO: Daniel S. McKinney

EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its propr...